Upstream Bio Statistics

Total Valuation

Upstream Bio has a market cap or net worth of $368.51 million. The enterprise value is -$100.10 million.

Market Cap	368.51M
Enterprise Value	-100.10M

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025, before market open.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Upstream Bio has 53.64 million shares outstanding. The number of shares has increased by 363.22% in one year.

Current Share Class	53.64M
Shares Outstanding	53.64M
Shares Change (YoY)	+363.22%
Shares Change (QoQ)	+1,411.72%
Owned by Insiders (%)	0.08%
Owned by Institutions (%)	58.27%
Float	31.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	39.66
Forward PS	144.98
PB Ratio	0.78
P/TBV Ratio	0.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 44.63, with a Debt / Equity ratio of 0.00.

Current Ratio	44.63
Quick Ratio	43.93
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -21.74% and return on invested capital (ROIC) is -16.77%.

Return on Equity (ROE)	-21.74%
Return on Assets (ROA)	-16.23%
Return on Invested Capital (ROIC)	-16.77%
Return on Capital Employed (ROCE)	-16.51%
Revenue Per Employee	$45,577
Profits Per Employee	-$1.47M
Employee Count	52
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	8.69
200-Day Moving Average	n/a
Relative Strength Index (RSI)	34.72
Average Volume (20 Days)	243,174

Short Selling Information

The latest short interest is 3.46 million, so 6.46% of the outstanding shares have been sold short.

Short Interest	3.46M
Short Previous Month	2.72M
Short % of Shares Out	6.46%
Short % of Float	11.12%
Short Ratio (days to cover)	10.79

Income Statement

In the last 12 months, Upstream Bio had revenue of $2.37 million and -$76.40 million in losses. Loss per share was -$5.58.

Revenue	2.37M
Gross Profit	2.37M
Operating Income	-77.76M
Pretax Income	-54.81M
Net Income	-76.40M
EBITDA	-77.68M
EBIT	-77.76M
Loss Per Share	-$5.58

Full Income Statement

Balance Sheet

The company has $470.45 million in cash and $1.83 million in debt, giving a net cash position of $468.62 million or $8.74 per share.

Cash & Cash Equivalents	470.45M
Total Debt	1.83M
Net Cash	468.62M
Net Cash Per Share	$8.74
Equity (Book Value)	469.85M
Book Value Per Share	8.77
Working Capital	468.42M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$59.17 million and capital expenditures -$511,000, giving a free cash flow of -$59.68 million.

Operating Cash Flow	-59.17M
Capital Expenditures	-511,000
Free Cash Flow	-59.68M
FCF Per Share	-$1.11

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-3,281.18%
Pretax Margin	-2,650.04%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Upstream Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-363.22%
Shareholder Yield	-363.22%
Earnings Yield	-20.73%
FCF Yield	-16.20%

Analyst Forecast

The average price target for Upstream Bio is $56.50, which is 722.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$56.50
Price Target Difference	722.42%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Upstream Bio has an Altman Z-Score of 46.28 and a Piotroski F-Score of 2.

Altman Z-Score	46.28
Piotroski F-Score	2